A Y ₁ receptor ligand stabilizes doxorubicin and P-gp inhibitor tariquidar co-loaded nanomicelles during systemic circulation, generating excellent tumor targeting and antitumor efficacy with prolonged survival and minimized liver metastasis.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: